Focus on Myeloma and Plasma Cell Disorders

Ultima Vez Modificado: 17 de octubre del 2003

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

FDA Approves Farydak for Multiple Myeloma

Feb 25, 2015

Drug is sanctioned for people who have received at least two prior standard therapies

Revised Staging System Prognostic for Multiple Myeloma

Aug 4, 2015

ISS plus chromosomal abnormalities, lactate dehydrogenase prognostic in multiple myeloma

Lenalidomide Maintenance Beneficial in Multiple Myeloma

May 11, 2012

Three studies show benefit of lenalidomide, including after induction therapy or stem-cell transplant